Thomas Bertelmann

Branch Retinal Vein Occlusion, Macular Ischemia, and Intravitreal Anti-VEGF Therapy

Thomas Bertelmann, Hans Ulrich Frank, Hendrik Ansgar Fuchs et al. · Case Reports in Ophthalmology · 2017 · 594 citations · Full text

One-year refractive results, contrast sensitivity, high-order aberrations and complications after myopic small-incision lenticule extraction (ReLEx SMILE)

Walter Sekundo, Jana Gertnere, Thomas Bertelmann et al. · Graefe s Archive for Clinical and Experimental Ophthalmology · 2014 · 203 citations

Vitreous Body, Ophthalmology, Contrast Sensitivity +8

Proteomics of Vitreous Humor of Patients with Exudative Age-Related Macular Degeneration

Michael Koss, Janosch Hoffmann, Nauke Nguyen et al. · PLoS ONE · 2014 · 99 citations · Full text

Clinical Efficacy and Safety of Ranibizumab Versus Dexamethasone for Central Retinal Vein Occlusion (COMRADE C): A European Label Study

Hans Hoerauf, Nicolas Feltgen, Eva‐Maria Paulus et al. · American Journal of Ophthalmology · 2016 · 85 citations

Diabetic Retinopathy, Ocular Disease, Vitreous Body +8

Head‐to‐head comparison of ranibizumab PRN versus single‐dose dexamethasone for branch retinal vein occlusion (COMRADE‐B)

Lars‐Olof Hattenbach, Nicolas Feltgen, Thomas Bertelmann et al. · Acta Ophthalmologica · 2017 · 64 citations · Full text